IP Library › Assignment 045480/0437
Patent Assignment
Reel/Frame 045480/0437

Security Interest

Recorded: 2018-04-09 Pages: 16
Assignors
PROVECTUS BIOPHARMACEUTICALS, INC.
Executed: 2017-10-19
PROVECTUS PHARMATECH, INC.
Executed: 2017-10-19
PROVECTUS BIOTECH, INC.
Executed: 2017-10-19
PURE-IFIC, INC.
Executed: 2017-10-19
Assignees
HANSEN, CHRIS
585 LAKE POINT DRIVE, PINEY FLATS, TENNESSEE, 37686
HANSEN, STEPHANIE
585 LAKE POINT DRIVE, PINEY FLATS, TENNESSEE, 37686
Covered Properties (21)
Method for Improved Imaging and Photodynamic Therapy
Patent: 6,493,570 →
Application: 09/184,388 →
Improved Methods for High Energy Phototherapeutics
Patent: 6,331,286 →
Application: 09/216,787 →
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,495,360 →
Application: 09/543,479 →
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,451,597 →
Application: 09/803,498 →
Publication: US 2001/0041354
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,541,223 →
Application: 09/803,609 →
Publication: US 2001/0044146
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,468,777 →
Application: 09/803,634 →
Publication: US 2001/0041361
Ultrasound Contrast Using Halogenated Xanthenes
Patent: 6,986,740 →
Application: 10/314,840 →
Publication: US 2003/0167006
Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of Disease
Patent: 6,991,776 →
Application: 10/331,854 →
Publication: US 2003/0125376
Combination Antiperspirant and Antimicrobial Composition
Patent: 7,201,914 →
Application: 10/425,255 →
Publication: US 2003/0215408
Intracorporeal Medicaments for Photodynamic Treatment of Disease
Patent: 7,402,299 →
Application: 10/999,313 →
Publication: US 2005/0154049
Methods for Positron Emission Imaging with Radiolabeled Halogenated Xanthenes Diagnostic Agents
Patent: 7,338,652 →
Application: 11/050,512 →
Publication: US 2005/0276753
Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of Disease
Patent: 8,470,296 →
Application: 11/715,780 →
Publication: US 2007/0208076
Topical Medicaments and Methods for Photodynamic Treatment of Disease
Patent: 8,974,363 →
Application: 11/936,963 →
Publication: US 2008/0118578
Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes
Patent: 8,530,675 →
Application: 12/884,833 →
Publication: US 2011/0071217
Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Patent: 9,107,887 →
Application: 13/416,494 →
Publication: US 2012/0263677
Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one(Rose Bengal) and Related Xanthenes
Patent: 9,422,260 →
Application: 13/916,408 →
Publication: US 2013/0274322
Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes
Patent: 9,273,022 →
Application: 14/447,063 →
Publication: US 2014/0343296
Combination of Local and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Application: 14/748,579 →
Publication: US 2015/0290309
Combination of Rose Bengal and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Patent: 9,839,688 →
Application: 14/748,608 →
Publication: US 2015/0290165
Combination of Local and Systemic Immunomodulative Therapies for Melanoma and Liver Cancer
Patent: 9,808,524 →
Application: 14/748,634 →
Publication: US 2015/0290318
Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound
Application: 14/974,357 →
Publication: US 2017/0173079
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 3, 2012
From: EAGLE, CRAIG J.
To: PFIZER, INC.
Reel/Frame 028485/0653 →
Assignment of Assignor's Interest Jul 3, 2012
From: DEES, H. CRAIG; WACHTER, ERIC A.; SINGER, JAMIE
To: PROVECTUS PHARMACEUTICALS, INC.
Reel/Frame 028485/0607 →
Assignment of Assignor's Interest Jan 19, 2016
From: SINGER, JAMIE; WACHTER, ERIC A.; LUTZ, MARLON; BABIAK, KEVIN
To: PROVECTUS PHARMACEUTICALS, INC.
Reel/Frame 037525/0138 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037648/0690 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037648/0389 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC
Reel/Frame 037648/0082 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037649/0217 →
Assignment of Assignor's Interest Feb 2, 2016
From: PROVECTUS PHARMACEUTICALS, INC.
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037649/0150 →
Security Interest Apr 4, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0389 →
Security Interest Apr 4, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0443 →
Security Interest Apr 4, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0498 →
Security Interest Apr 21, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0516 →
Security Interest Apr 21, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0594 →
Security Interest Apr 21, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0421 →
Security Interest Jun 26, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SCOTT A.; TAUSK, SANDRA J.
Reel/Frame 042809/0878 →
Security Interest Jun 26, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SANDRA J.; TAUSK, SCOTT A.
Reel/Frame 042809/0817 →
Security Interest Jun 26, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SCOTT A.; TAUSK, SANDRA J.
Reel/Frame 042809/0755 →
Security Interest Aug 1, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043156/0410 →
Security Interest Aug 1, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043157/0439 →
Security Interest Aug 1, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043157/0330 →
Security Interest Aug 9, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043244/0210 →
Security Interest Aug 9, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043244/0424 →
Security Interest Aug 9, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043245/0875 →
Security Interest Apr 9, 2018
From: PROVECTUS BIOPHARMACEUTICALS, INC.; PROVECTUS PHARMATECH, INC.; PROVECTUS BIOTECH, INC.; PURE-IFIC, INC.
To: FORTUNATO, PAUL M.; FORTUNATO, KATHLEEN E.
Reel/Frame 045478/0511 →
Security Interest Apr 9, 2018
From: PROVECTUS BIOPHARMACEUTICALS, INC.; PROVECTUS PHARMATECH, INC.; PROVECTUS BIOTECH, INC.; PURE-IFIC, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 045480/0690 →